Nanohale AG to be listed on Frankfurt Stock Exchange as of December 20
“By way of this exchange listing, we aim to strengthen perceptions of our company, particularly in the context of establishing further strategic partnerships in Germany and elsewhere,” said Dr. Nicolas Combé, CFO of Nanohale AG, in explaining the motivations for the listing.   [more]

instrAction and Protagen from strategic Alliance
instrAction GmbH, Ludwigshafen, the specialist for design and production of selective separation matrices and Protagen AG, Dortmund, a GMP certified service laboratory for protein analysis signed a strategic alliance for the development of customized instrAction® Phases for downstream processing of biotherapeutics.  [more]

Euroimmun to use Scienion Arrayer for Biochip Development and Production
Scienion AG announced on February 21, 2011 that EUROIMMUN AG - one of the leading manufacturers of immuno-biochemical assays - has purchased Scienion`s sciFLEXARRAYER technology to develop multiplexed diagnostic products and to produce new test formats.  [more]

InterMed Discovery aquires sustainable source for Omega-3 Fatty Acid
InterMed Discovery (IMD), a word class natural product lead-discovery company - based in the BioMedizinZentrumDortmund, anounced the acquisition of unique microbial Omega-3 fatty acid production strains and related know-how from the University of Saarland. This innovative microbial source has the potential to produce Omega-3 more sustainable and reliably compared to established sources.  [more]

Protagen and OncoTyrol form strategic alliance to validate the UNIarray® technology platform
Dortmund, Germany and New Jersey, USA, June 10, 2009. Protagen AG and the Medical University Innsbruck, Department of Urology, have recently identified autoantigen candidates present in serum of patients with prostate cancer using the proprietary UNIArray® technology platform. In Europe, prostate cancer is the second most frequent lethal malignancy in men. Yearly about 40,000 men die of prostate cancer in the European Union.   [more]

InterMed Discovery Closes Equity Transaction Worth €7,44 M with Biotropics Malaysia Berhad
Dortmund, Germany, January 13, 2009 – InterMed Discovery (IMD), an emerging world class natural product lead-discovery company, today announced the close of an equity transaction worth €7.44 million with Biotropics Malaysia Berhad.   [more]

Chimera Biotech receives the European Frost & Sullivan Award 2008 for the Imperacer
The 2008 European Immunoassay Frost & Sullivan Excellence in Technology Award has been awarded to Chimera Biotec, a bioanalytical company based in the BioMedizinZentrumDortmund, Germany. Chimera Biotec is recognized for its pioneering Imperacer® ultrasensitive immunoassay system, which has a 1000-fold better sensitivity compared to ELISA (Enzymelinked Immunosorbent Assay).   [more]

Dortmund / Stockholm, Juni 2008: Process Relations introduces XperiDesk at Replisaurus Technologies
Process Relations establishes the Process Development Execution System (PDES) at the developers of the patented ECPR™ Technology.   [more]

Protagen raises €1 million to expand its protein biochips business unit
Dortmund, Germany and New Jersey, USA, 15. January 2008: Protagen AG, a leading provider of products, services and software solutions for protein research, announces the closing of an interim financing round. The €1 million raised will be used to expand the company`s protein biochips business unit.  [more]

Process Relations, located in TechnologieZentrumDortmund, breaks new ground with the High-Tech Gründerfonds and SeedCapital Dortmund
The company based in Dortmund, Germany is commercializing and advancing the results of the EU 6th framework founded project "PROMENADE" and will help to structure and speed up the development of silicon based manufacturing processes.  [more]